Physician profile
Brea Mclaughlin
NPI 1710230974
$1,552.85
in general payments reported to CMS, 2019-2025
9 companies · $478 in 2025
The $478 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $563 · 2024: $511 · 2025: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,552.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $572.51 | 2023-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Astrazeneca Pharmaceuticals Lp | $277.78 | 2023-2025 | Farxiga |
| Abiomed | $269.49 | 2023-2025 | Impella |
| Medtronic, INC. | $153.52 | 2025 | Corevalve Evolut R |
| E.R. Squibb & Sons, L.L.C. | $118.68 | 2023-2024 | Camzyos |
| Paragonix Technologies, INC. | $43.88 | 2025 | Sherpapak |
| Merck Sharp & Dohme LLC | $43.42 | 2024 | Winrevair |
| Actelion Pharmaceuticals US, INC. | $42.95 | 2023-2024 | Opsumit, Uptravi |
| Pfizer INC. | $30.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brea Mclaughlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.